Table:
begin	end	state
1	19	cytoplasmic
20	38	transmembrane
39	56	non-cytoplasmic
57	78	transmembrane
79	89	cytoplasmic
90	136	transmembrane
137	156	cytoplasmic
157	174	transmembrane
175	179	non-cytoplasmic
180	198	transmembrane
199	243	cytoplasmic
244	264	transmembrane
265	275	non-cytoplasmic
276	301	transmembrane
302	312	cytoplasmic
313	332	transmembrane
333	337	non-cytoplasmic
338	359	transmembrane
360	371	cytoplasmic
372	394	transmembrane
395	401	non-cytoplasmic
402	422	transmembrane
423	455	cytoplasmic

Input:
>WP_012385184.1 NCBI__GCF_000019845.1:WP_012385184.1
MAAGFQGGLVQAAKRTATTTTGRVFGLICLMYFITYVDRVNVSTLAPLMSKELGLSNIQL
GLVLSAFGYPYALLQILGGTAADKFGARKTLTICGGIWALSTIATGFVGGLFSLLLVRIF
VGIGEGATFPAATRAMASWVPESRRGYAQGMVHSASRLANAITPPLVILIAAYLGWRGAF
LALGCVSMVWVLAWLFYFRDNPRDHTGVSLQEIALLPEPRQKTQAGAVKVPWGPLTRAMM
PTTLVYFCYNWTFWLYITWLPSYFVQAYGLELKHMAAFTFAIFAAGVVGDTLGGVLTDFV
YHRTGDLPASRRLVVVFSLIASMICLIPALFVHDLVTIGFSLASAFFFLELTVGPIWAVP
MDIAPHFSGTASGIMNTGSAIAGIVSPIAFGLVIDLTHSYTLPFYGSVLLLMIGACIAFF
FMPSRGLVASSATENATTGQANSPRISTMRDVAGQ

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server